Bafna Pharmaceuticals Ltd. - Research Center
532989 BAFNAPH Group (T) BSE data
Add to watchlist
| Results | |
| Statement |
Balance sheet
|
| More |
Balance sheet
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Sources of funds | |||||
| Owner's fund | |||||
| Equity share capital | 23.66 | 23.66 | 23.66 | 2.37 | 23.66 |
| Share application money | - | - | - | 55.36 | - |
| Preference share capital | - | - | - | - | - |
| Reserves & surplus | 49.80 | 39.22 | 33.11 | -6.78 | -2.86 |
| Loan funds | |||||
| Secured loans | 22.92 | 7.89 | 2.50 | 3.02 | 46.23 |
| Unsecured loans | - | - | - | - | - |
| Total | 96.38 | 70.77 | 59.27 | 53.96 | 67.02 |
| Uses of funds | |||||
| Fixed assets | |||||
| Gross block | 94.66 | 87.94 | 79.57 | 74.09 | 72.87 |
| Less : revaluation reserve | - | - | - | - | - |
| Less : accumulated depreciation | 54.43 | 49.09 | 43.60 | 39.12 | 35.85 |
| Net block | 40.23 | 38.85 | 35.97 | 34.97 | 37.02 |
| Capital work-in-progress | 1.50 | - | 0.83 | 0.21 | - |
| Investments | - | - | - | - | 1.43 |
| Net current assets | |||||
| Current assets, loans & advances | 87.85 | 51.40 | 49.67 | 35.88 | 82.19 |
| Less : current liabilities & provisions | 33.20 | 19.47 | 27.19 | 17.10 | 53.62 |
| Total net current assets | 54.65 | 31.93 | 22.47 | 18.78 | 28.57 |
| Miscellaneous expenses not written | - | - | - | - | - |
| Total | 96.38 | 70.77 | 59.27 | 53.96 | 67.02 |
| Notes: | |||||
| Book value of unquoted investments | - | - | - | - | 1.43 |
| Market value of quoted investments | - | - | - | - | - |
| Contingent liabilities | 10.48 | 2.42 | - | - | - |
| Number of equity sharesoutstanding (Lacs) | 236.56 | 236.56 | 236.56 | 23.66 | 236.56 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis